zuelligpharma.com

We performed a comprehensive analysis of zuelligpharma.com on 2026-07-06. The website returned an HTTP 200 status code with a server response time of 6865ms. The page is served over HTTP/2 protocol with Gzip compression enabled, achieving approximately 60.0% size reduction. The total page weight is 116 KB. The website uses a secure HTTPS connection with a valid SSL certificate issued by DigiCert Inc (OV type). The connection is encrypted using TLS 1.3 with the TLS_AES_256_GCM_SHA384 cipher suite and ECDSA-SHA384 signature algorithm. The certificate covers 3 domain(s) (Subject Alternative Names) and expires on 2026-12-06, which is 153 days from now. The security headers analysis reveals a score of 80/100 (good). The following security headers are properly configured: Strict-Transport-Security (HSTS), X-Frame-Options, X-Content-Type-Options, Referrer-Policy, and Permissions-Policy. However, the site is missing Content-Security-Policy, which could expose the site and its users to cross-site scripting (XSS), clickjacking, and other web-based attacks. Our technology detection scan identified 7 technologies across 6 categories powering zuelligpharma.com. The detected stack includes Next.js css, Webpack, Google Analytics 4, Microsoft Clarity, Google Tag Manager, LinkedIn Insight Tag, and Akamai. The site uses Next.js as its primary framework (version css). Based on our comprehensive analysis of domain age, SSL configuration, email authentication, security headers, and blacklist status, zuelligpharma.com receives an overall trust score of 80/100, classified as "Very Likely Safe".

After conducting a thorough safety and legitimacy analysis, zuelligpharma.com receives a trust score of 80/100, which places it in the "Very Likely Safe" category. This score is calculated by evaluating multiple factors including SSL certificate validity, domain registration history, email authentication protocols, security header configuration, and blacklist status across major threat intelligence databases. The analysis identified several positive trust signals: a valid HTTPS connection protecting data in transit, HSTS (HTTP Strict Transport Security) enforcement preventing protocol downgrade attacks, a valid SSL certificate issued by DigiCert Inc with 153 days until expiration, SPF (Sender Policy Framework) email authentication preventing email spoofing, and DMARC email authentication with a quarantine policy. Areas of concern include: the absence of a Content-Security-Policy header, which leaves the site more vulnerable to cross-site scripting (XSS) attacks, the domain's WHOIS information is hidden behind a privacy service, making it harder to verify the owner's identity, and DNSSEC is not enabled, leaving DNS queries vulnerable to spoofing attacks. While these issues don't necessarily indicate malicious intent, they represent areas where the website's security posture could be improved. We checked zuelligpharma.com against 8 major blacklist databases including Google Safe Browsing, Phishtank, Urlhaus, Openphish, Dnsfilter, Spamhaus Dbl, Surbl, and Virustotal. The domain passed all 8 checks with a clean status, meaning it has not been flagged for phishing, malware distribution, spam, or other malicious activities by any of the tested threat intelligence providers.

Our technology detection engine scanned zuelligpharma.com and identified 7 distinct technologies across 6 categories. This analysis is performed by examining HTTP response headers, HTML source code patterns, JavaScript library fingerprints, CSS framework signatures, and DNS records. Framework: Next.js (version css) — provides the application framework and routing for zuelligpharma.com. Build Tool: Webpack — bundles and optimizes the JavaScript and CSS assets for zuelligpharma.com. Analytics: Google Analytics 4 and Microsoft Clarity — tracks visitor behavior and provides traffic insights for zuelligpharma.com. Tag Manager: Google Tag Manager — manages marketing and analytics tags without code changes for zuelligpharma.com. Advertising: LinkedIn Insight Tag — handles advertising pixel tracking and conversion measurement for zuelligpharma.com. CDN: Akamai — accelerates content delivery by caching assets at edge locations worldwide for zuelligpharma.com. We also extracted the following tracking identifiers: Google Analytics 4 Measurement ID G-BVQKYN05X3 and Google Tag Manager container GTM-NHB97CK. These IDs can be used to identify other websites operated by the same organization.

zuelligpharma.com delivers its homepage in 6865ms (server response time), which is considered slow by industry standards. The total page weight is 116 KB, and we detected 152 resource requests loading assets from 4 third-party domains. A high number of third-party domains can significantly impact page load time due to additional DNS lookups and TLS handshakes required for each domain. The website uses Gzip compression for text-based assets, achieving an estimated 60.0% reduction in transfer size. This reduces bandwidth usage and improves page load times, especially for visitors on slower connections. Asset minification status: 0 out of 1 CSS files and 0 out of 12 JavaScript files are minified. Minifying the remaining 13 unminified file(s) could further reduce page weight by 10-30% for those assets. Minification is a best practice that reduces download sizes without affecting functionality. From an environmental perspective, each page view of zuelligpharma.com produces approximately 0.06g of CO₂, earning a carbon rating of A. This places the website among the cleanest on the web, demonstrating efficient use of server resources and optimized content delivery. For reference, the average web page produces about 0.5g of CO₂ per page view. The page weight of 116 KB is the primary factor in this calculation. Core Web Vitals data from the Chrome User Experience Report (CrUX) is not available for zuelligpharma.com. This typically means the site doesn't have enough real-world Chrome user traffic to generate statistically significant field data, or the domain is not included in the CrUX dataset. Core Web Vitals (LCP, INP, CLS) are important Google ranking factors that measure real user experience.

zuelligpharma.com resolves to the IPv4 address 2.16.6.18 and also supports IPv6 (2a02:26f0:7100::210:111), demonstrating modern network infrastructure readiness. The domain has 2 A record(s) configured. The domain name system is managed by 6 name servers: a1-54.akam.net, a20-64.akam.net, a28-64.akam.net, a5-67.akam.net, a8-64.akam.net, and a9-64.akam.net. Having 6 name servers provides good redundancy — if one fails, the others can continue serving DNS queries. The choice of name servers often indicates the DNS hosting provider or CDN service being used. Email for zuelligpharma.com is handled by messagelabs.com with 3 MX records configured: cluster1.us.messagelabs.com, cluster1a.us.messagelabs.com, and zuelligpharma-com.mail.protection.outlook.com. Multiple MX records provide failover redundancy — if the primary mail server is unavailable, email will be routed to the next available server. SPF (Sender Policy Framework) is configured, which specifies which mail servers are authorized to send email on behalf of this domain. This helps prevent email spoofing and improves email deliverability. DMARC (Domain-based Message Authentication, Reporting and Conformance) is configured with a quarantine policy — a moderate setting, directing unauthorized emails to spam/junk folders. DKIM was not detected. Without DKIM, recipients cannot cryptographically verify that emails claiming to be from this domain are authentic. DNSSEC is not enabled for zuelligpharma.com. While not critical for most websites, DNSSEC adds an important security layer by ensuring DNS responses haven't been tampered with during transit. Enabling DNSSEC is recommended for domains handling sensitive data or financial transactions.

The homepage of zuelligpharma.com contains 564 words of visible text content. This is a moderate amount of content. The page is structured with 0 H2 headings, 1 H3 headings, 0 H4 headings. The page includes 46 images. 16 images (35%) are missing alt text attributes, which is a significant concern for both accessibility and SEO. Screen readers rely on alt text to describe images to visually impaired users, and search engines use alt text to understand image content. Only 65% of images have proper alt text — we recommend adding descriptive alt attributes to all images. The link structure consists of 80 internal links pointing to other pages on the same domain and 4 external links pointing to third-party websites. There are 12 external JavaScript files, 1 CSS stylesheets, and 1 iframes on the page. The site implements the following web standards and features: XML Sitemap (helps search engines discover all pages), robots.txt (controls search engine crawling behavior), and Schema.org structured data (Answer, Corporation, FAQPage, Question, SearchAction, and WebSite). We detected the following payment methods accepted on zuelligpharma.com: Discover. Offering multiple payment options including credit cards and digital wallets improves customer trust and can increase conversion rates. The website has social media presence across 1 platforms: Linkedin (@zuellig-pharma). An active social media presence is a positive trust indicator and helps build brand awareness and customer engagement.

The title tag for zuelligpharma.com is well-optimized at 50 characters: "Making Healthcare More Accessible - Zuellig Pharma". The length falls within the ideal range for Google search results, ensuring the full title is displayed without truncation. The meta description is 159 characters (acceptable): "Zuellig Pharma is Asia's leading healthcare solutions company offering a broad range of healthcare solutions with a miss...". Google typically displays up to 155-160 characters of the meta description in search results. A compelling meta description with a clear call-to-action can significantly improve click-through rates from search results. The canonical url is correctly set to https://zuelligpharma.com/, preventing duplicate content issues, the page language is declared as en, and a favicon is configured. Open Graph meta tags are configured with 3/4 recommended fields: OG title ("Making Healthcare More Accessible - Zuellig Pharma..."), OG description, OG image (social sharing thumbnail), These tags control how the page appears when shared on Facebook, LinkedIn, and other social media platforms that support the Open Graph protocol. The site implements Schema.org structured data with the following types: Answer, Corporation, FAQPage, Question, SearchAction, and WebSite. Structured data helps search engines understand the page content and can enable rich results (featured snippets, knowledge panels, star ratings) in Google search results, which can significantly increase click-through rates. The meta keywords tag contains 11 terms including healthcare solutions, pharmaceutical distribution, healthcare commercialization, patient care, and clinical trials. Note: Google has officially confirmed that it does not use the meta keywords tag as a ranking signal. However, some other search engines (Bing, Yandex) may still reference it.